IVF Hartmann Holding AG (LON:0QQM)
137.00
0.00 (0.00%)
At close: Oct 31, 2025
IVF Hartmann Holding AG Revenue
IVF Hartmann Holding AG had revenue of 77.16M CHF in the half year ending June 30, 2025, with 7.82% growth. This brings the company's revenue in the last twelve months to 159.69M, up 4.20% year-over-year. In the year 2024, IVF Hartmann Holding AG had annual revenue of 159.03M with 7.23% growth.
Revenue (ttm)
159.69M CHF
Revenue Growth
+4.20%
P/S Ratio
2.10
Revenue / Employee
591.21K CHF
Employees
270
Market Cap
307.14M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159.03M | 10.72M | 7.23% |
| Dec 31, 2023 | 148.31M | -2.84M | -1.88% |
| Dec 31, 2022 | 151.15M | 6.35M | 4.38% |
| Dec 31, 2021 | 144.80M | -29.16M | -16.76% |
| Dec 31, 2020 | 173.96M | 34.94M | 25.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |